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Introduction 
  Essential hypertension in adolescents (ages 12-17) has received greater 
attention in recent years than in the past.  According to the fourth report from the 
National High Blood Pressure Education Program (NHBPEP) essential hypertension is 
now a common occurrence among adolescents in the United States (U.S.) (NHBPEP, 
2004).  While hypertension in the very young is almost always due to an underlying 
secondary cause, most cases of high blood pressure encountered in adolescents (ages 
12-17) have no known cause (Flynn, 2001).  There have been several longitudinal 
studies over the last several decades illustrating the tendency for children and 
adolescents with even moderately elevated blood pressure to develop high blood 
pressure as adults (Bao, 1995; Lauer, 1989; Wilson, 1997). 
  Obesity rates among adolescents in the U.S. continue to grow profoundly. 
According to a survey conducted over 1999-2000 by the Third National Nutrition 
Examination Survey (NHANES III), 15.5% of 6 to 19 year-olds are overweight, with body 
mass indices (BMI) greater than the 95
th percentile for their age (Ogden, 2002).  Obesity 
not only enhances the risk of developing essential hypertension, especially in those that 
are genetically predisposed, but these individuals are also more likely to have problems 
with dyslipidemia and type 2 diabetes mellitus.  The long-term consequences of poorly-
controlled essential hypertension have been shown to significantly increase premature 
morbidity and mortality.  Now more than ever, healthcare providers must be aware of 
these consequences.  It is imperative that providers routinely screen adolescents for 
hypertension at every clinical visit in order to minimize the risk of developing the serious 
medical complications associated with long-standing hypertension    - 2 - 
Problem Statement: 
  Elevated arterial blood pressure among adolescents in the U.S. has become an 
area of significant concern due to increasing prevalence.  Long-standing poorly-
controlled essential hypertension has been directly linked to very serious conditions 
including, heart disease, stroke, and kidney disease.    
Research Hypothesis: 
  Pediatrician providers are more proficient than non-pediatrician providers in 
detecting and appropriately treating adolescents (ages 12-17) with essential 
hypertension. 
Purpose: 
  The purpose of this study was to gain an understanding of current knowledge 
levels between pediatrician providers and non-pediatrician providers in detecting and 
appropriately treating adolescents (ages 12-17) with essential hypertension.  The 
relevance of this study is associated with the increasing prevalence of obesity, and 
often subsequent increase in arterial blood pressure, among adolescents in the U.S.  
Based on research illustrating the harmful effects of long-standing essential 
hypertension, it would be simply unacceptable to fail in identifying and adequately 
treating patients in this population.  As essential hypertension becomes a more common 
problem in adolescents, healthcare providers must be highly proficient in recognizing 
abnormal BP measurements, and knowledgeable with BP reduction methods.          
 
 
 - 3 - 
Literature Review 
Pathogenesis of Hypertension 
Systemic arterial pressure is influenced by two physiologic variables: cardiac 
output and total peripheral resistance.  Hypertension is usually due to increased 
peripheral resistance (Schoen, 2003).  However, blood pressure (BP) can also be 
altered through an increase in cardiac output.  Hypertension induced by increased 
cardiac output is commonly due to sodium imbalances.  In humans, the etiology of 
hypertension is unknown (essential) in about 90-95% of cases of elevated BP (Fisher, 
2005).   
Essential Hypertension:   
There are several factors involved in the development of essential hypertension.  
Genetics play a huge role in essential hypertension.  It is thought that a number of 
different gene defects combine to express elevated BP.  Environmental factors such as 
age, gender, race, weight, cholesterol levels, glucose intolerance, and in some cases, 
salt intake, are thought to play a role in the pathogenesis of hypertension, each to 
varying degrees (Schoen, 2003)   
  Essential hypertension is very complex in nature. So far, scientists have been 
unable to fully understand its pathogenesis.  At this point, essential hypertension is 
treatable but incurable.  Studies have shown that as patients age, especially those that 
are untreated, further increases in arterial pressure can be expected (Fisher, 2005). 
Secondary Hypertension:  
  Secondary hypertension deals with specific causes of elevated arterial pressure 
that are identifiable and curable.  An estimated 5-10% of individuals with high BP fall - 4 - 
into this category.  The vast majority of cases involve the kidneys.  This can be further 
broken down into renovascular and renal parenchymal hypertension.  In renovascular 
hypertension, stenosis of renal artery perfusion is interrupted, and the renin-angiotensin 
system is activated.  Angiotensin II elevates blood pressure through vasoconstriction.  
Angiotensin II also stimulates the release of aldosterone, which contributes to elevated 
BP primarily by promoting sodium retention (Ganong, 2005).  It is believed that renal 
parenchymal disease ultimately results in hypertension through activation of the renin-
angiotensin system as well.  In this condition, however, decreased renal perfusion 
results from inflammatory and fibrotic changes in small intrarenal vessels (Ganong, 
2005).  
  Endocrine abnormalities are another cause behind secondary hypertension in 
some cases.  The adrenal cortex is responsible for a number of abnormalities that result 
in elevated BP.  In primary aldosteronism, plasma sodium is retained and volume is 
expanded.  Since potassium is shed in order to retain plasma sodium, patients will have 
low levels of potassium (Ganong, 2005).  Cushing’s syndrome and pheochromocytoma 
are two other examples of endocrine disorders that lead to secondary hypertension.   
  Other examples of causes of secondary hypertension include coarctation of the 
aorta, hypercalcemia, polycythemia vera, polyarteritis nodosa, and medications, such as 
steroids (Fisher, 2005).  As previously mentioned, the hypertension associated with 
many of these conditions can be cured, unlike in essential hypertension.  However, as 
scientists are able to further explore secondary causes of hypertension, there is a 
greater possibility that achievements can be made in understanding the pathogenesis of 
essential hypertension.  - 5 - 
  The majority of hypertension, while still harmful, is not usually associated with 
death within a few short years of its onset.  Malignant hypertension accounts for only a 
small (estimated 5%) percentage of individuals with elevated arterial pressure.  The 
etiology may consist of either secondary or idiopathic (essential) causes.  In malignant 
hypertension, the elevated blood pressure goes undetected while even greater 
increases are seen within a short time period.  Diastolic pressures are typically greater 
than 120 mmHg (Schoen, 2003).  On the other end of the spectrum is benign 
hypertension, which accounts for the vast majority of cases.        
Prevalence of Hypertension in the Adolescent Population 
  Poorly controlled essential hypertension continues to be a major contributor to 
premature morbidity and mortality in the U.S.  It is strongly associated with many of the 
common disease processes seen in developed nations, such as cardiac, 
cerebrovascular, and renal disease.  Despite being relatively easy to detect and 
adequately treat, there is still a significant number of people living with poorly controlled 
hypertension.  In fact, as illustrated in the Framingham Study, roughly one-fifth of 
individuals had blood pressures greater than 140/90 mmHg in a white, suburban 
population sampled (Lloyd-Jones, 1999).  
  Elevated arterial blood pressure is not a problem exclusive to the adult 
population.  While hypertension in infants and young children is almost always due to an 
underlying secondary cause, the majority of high blood pressure seen in the adolescent 
population is of an unknown etiology (Flynn, 2001).  There have been several 
longitudinal studies over the last several decades illustrating the tendency for children 
and adolescents with even moderately elevated blood pressure to develop high blood - 6 - 
pressure as adults.  This trend is compounded further in obese individuals and those 
with family histories of essential hypertension.  The Bogalusa Heart study, conducted in 
Bogalusa, LA, examined BP progression in 1,501 subjects, between 2 and 24 years old, 
over several decades.  Their results concluded that BP definitely tracks from childhood 
into adulthood.  Their most prominent correlation with elevated BP persisting into 
adulthood involved subjects between the ages of 10 to 14 years.  Normotensive 
subjects remained normotensive, while 68% with systolic BP greater than the 75
th 
percentile for age remained in the upper quartile into the 9
th year of follow-up (Bao, 
1995). 
  The Muscatine study, conducted in Muscatine, Iowa, examined 2,445 children 
between the ages of 7-18 years.  Blood pressure, height, and weight were recorded 
over the years 1971 to 1978.  A sub-group was then recalled for repeat assessment 
between the ages of 23-28 years.  The study concluded that those with systolic BP 
greater than the 90
th percentile in childhood were four times more likely to have 
hypertension persisting into adulthood than those with normal systolic blood pressures.  
Findings for subjects with diastolic pressures greater than the 90
th percentile were not 
as significant as with systolic pressures, but these individuals were still twice as likely to 
develop hypertension as adults (Lauer, 1989).  The Framingham study also showed 
similar findings, indicating that elevated blood pressure in childhood and adolescence 
were more likely to continue into adulthood (Wilson, 1997). 
Effects of Hypertension and Contributing Factors 
  The risk of premature death has been shown to be much greater in individuals 
with hypertension than in normotensive individuals.  Chronic hypertension can have - 7 - 
serious effects on cardiac function itself.  As cardiac muscle works against an increased 
pressure for an extended time period, this compensatory mechanism results in 
hypertrophy of the left ventricle.  Eventually the function of the left ventricle becomes 
severely compromised because of the increased mass.  The majority of deaths related 
to long-standing hypertension are congestive heart failure (CHF), and acute myocardial 
infarction (AMI) (Fisher, 2005).     
There have been a number of studies involving the association of long-standing 
essential hypertension and increased left ventricular mass in adolescents.  A study by 
Cook et al. showed a greater left ventricular mass in 10-16 year-olds that had a family 
history of essential hypertension, when measured against comparable subjects without 
histories of familial hypertension (Cook, 2000).  Another study by Daniels et al. looked 
at children and adolescents with essential hypertension to determine the prevalence of 
left ventricular hypertrophy.  Increases greater than the 99
th percentile for left ventricular 
mass in normal individuals were designated the cut point for this study (Daniels, 1998).  
De Simone et al. had previously found that a left ventricular mass index greater than 51 
g/m^2.7 is associated with a fourfold increased risk of developing cardiovascular 
disease as an adult (de Simone, 1995).  The study showed that 14% of the subjects had 
severe left ventricular hypertrophy, and another 17% had abnormal left ventricular 
geometry.  Increased body mass was shown to have a strong positive correlation with 
essential hypertension and development of left ventricular hypertrophy, further 
illustrating the need for weight loss in overweight children and adolescents (Daniels, 
1998).  - 8 - 
A separate study by Daniels et al. examined left atrial hypertrophy in children and 
adolescents with essential hypertension.  Essential hypertension was associated with 
left atrial hypertrophy in 51% of the 112 patients sampled (Daniels, 2002).  Unlike many 
similar studies in the past that measure left ventricular mass, this study looked at atrial 
hypertrophy, which could eventually lead to problems such as atrial fibrillation, stroke, 
and congestive heart failure (Daniels, 2002).   
Atrial fibrillation is a very common arrhythmia in the United States.  This irregular 
rhythm is frequently associated with long-standing hypertension.  A study by Healey 
points out that hypertension has far surpassed rheumatic heart disease as the most 
common cause of sustained atrial fibrillation in North America (Healey, 2003).  Several 
factors are associated with the eventual development of atrial fibrillation.  Left 
ventricular hypertrophy, and left atrial enlargement account for the structural changes 
described in this study.  Changes in atrial electrophysiology occur early in the 
hypertension process, prior to appreciable structural changes.  Slowing of the atrial 
conduction velocity occurs.  Premature atrial contractions then become frequent as 
hypertension is left untreated, often precipitating atrial fibrillation.  Individuals with atrial 
fibrillation have a 3- to 6-fold increased risk of stroke compared to those without this 
arrhythmia (Healey, 2003).  The mechanism involves clot formation in the fibrillating 
atria.  These clots can then travel to many locations in the body and become lodged, 
thus disrupting blood flow.  The brain is frequently a target of these clots.  This statistic 
is worsened further when untreated hypertension is factored into the equation.  Patients 
must receive oral anticoagulation to prevent thromboembolic events from occurring.  
The study also claims that treatment of hypertension through pharmacologic means has - 9 - 
shown promise for eliminating atrial fibrillation, by reversing left atrial enlargement, and 
LVH (Healey, 2003).    
Now more than ever, adolescents between the ages of 12-17 in the U.S. are at 
high risk for developing essential hypertension at an early age.  Obesity in the U.S. has 
reached epidemic proportions among adolescents.  According to a survey conducted 
over 1999-2000 by the Third National Nutrition Examination Survey (NHANES III), 
15.5% of 6 to 19 year-olds are overweight, with body mass indices (BMI) greater than 
the 95
th percentile for their age.  Obesity is even more widespread among minority 
populations, with an estimated 23.6% of African Americans overweight among 
individuals between the ages of 6 and 19 years (Ogden, 2002).   
  The Bogalusa Study, conducted in Louisiana, examined trends in obesity in 
children and young adults, between the ages of 5 and 24 years, over an extended 
period of time.  Defining overweight as the 85
th percentile of weight for height, there was 
a twofold increase in prevalence in overweight individuals from 1973 to 1994.  The 
study also showed that overweight children had a 1.5 to twofold increased likelihood of 
being heavy as adults (Freedman, 1997).  The prevalence of overweight individuals was 
increased in both genders, and among African Americans and Caucasians.  Unlike in 
many other studies, African Americans were not found to be at higher risk of becoming 
overweight when compared with Caucasians (Freedman, 1997). 
Obesity alone has been shown to be a detriment to maintaining a healthy 
lifestyle.  Several articles have considered the implications of being overweight as an 
adolescent.  A study by He et al. determined truncal obesity to be a predictor of 
elevated systolic and diastolic blood pressure in boys in all stages of puberty.  The - 10 - 
study looked at individuals of African American, Asian, and Caucasian descent.  The 
results did not indicate any significant differences among races.  Unlike males, females 
did not show a positive correlation between high central fat deposition and elevated 
blood pressure (He, 2002).  
  Overweight adolescents are also more likely to have problems with dyslipidemia, 
type 2 diabetes mellitus, and of course, hypertension.  These are all major independent 
risk factors in the development of cardiovascular disease.  The metabolic syndrome, 
also known as syndrome X, describes this cluster of health problems that can ultimately 
lead to many adverse health consequences.  The metabolic syndrome has been 
defined by the Third Report of the Adult Treatment Panel (ATP III) as three or more of 
the following: hypertriglyceridemia, low high-density Lipoprotein (HDL), elevated fasting 
glucose, excessive waist circumference, and hypertension (ATP III, 2002).  The 
metabolic syndrome serves as an assessment tool for clinicians when evaluating adults 
in the development of cardiovascular disease and diabetes mellitus.  As of yet, no 
nationally accepted definition of the metabolic syndrome has been designated for 
children and adolescents.  Ferranti et al examined adolescents, ages 12-19 years old, in 
order to determine the prevalence of the metabolic syndrome in this population.  They 
used the ATP III guidelines with adjustments based on age.  To fit their definition, 3 or 
more of the following were required: “Fasting triglycerides >100 mg/dL, HDL <50 mg/dL, 
except in boys aged 15 to 19 years, in whom the cutpoint was 45 mg/dL, fasting glucose 
>110 mg/dL, waist circumference >75
th percentile for age and gender, and systolic 
blood pressure >90
th percentile for gender, age, and height” (Ferranti, 2004).  Their 
results indicated that an estimated 1 in 10 adolescents fits the definition of the metabolic - 11 - 
syndrome (Ferranti, 2004).  Another article by Cook reviewed several studies involving 
the metabolic syndrome in the pediatric population.  One example was by Goodman et 
al., who used adult standards in their assessment of the metabolic syndrome in teens 
(Goodman, 2004).  As expected, very conservative numbers were obtained, with only 
4.2% of teens meeting the ATP III guidelines (Cook, 2004). Cook emphasized the need 
for a definition of the metabolic syndrome in children and adolescents in order to better 
assess its prevalence in the pediatric and adolescent population. 
   It has been proposed in scientific literature that conditions favoring thrombotic 
events (prothrombotic states), as seen in myocardial infarction and stroke, are present 
in patients with hypertension and atherosclerosis.  Felmeden et al. hypothesized that an 
increased state of thrombogenesis could be related to endothelial damage/dysfunction 
and abnormal angiogenesis (Felmeden, 2003).  The study evaluated endothelial 
damage and prothrombotic states by measuring tissue factor (TF), von Willebrand 
Factor (vWF), flow-mediated dilatation (FMD), and vascular endothelial growth factor 
(VEGF).  It was hypothesized that 6 months of anti-hypertensive therapy, and in some 
cases hypercholesterolemia treatment, would favorably alter the above factors, thus 
decreasing the risk for serious cardiovascular events.  Their results confirmed the 
concept that abnormal thrombogenesis and angiogenesis, and endothelial 
damage/dysfunction are present in individuals with hypertension.  It was also shown 
that significant improvements were made in participants’ cardiovascular risk factor 
profiles following 6 months of pharmacologic treatment (Felmeden, 2003).  Another 
study by Endemann et al. reinforces the idea of endothelial damage/dysfunction in 
individuals with hypertension, and its role in cardiovascular disease states.  Along with - 12 - 
prothrombotic conditions, proinflammatory states, and reduced vasodilatory capacity 
also comprise the concept of endothelial dysfunction (Endemann, 2004).    
  Vascular health can suffer as a result of long-standing hypertension.  In the 
Atherosclerosis Risk in Young Adults (ARYA) study, Vos et al. reviewed old health 
records of men and women between the ages of 27 and 30 years in order to obtain their 
blood pressure measurements during their early adolescent years.  Researchers then 
proceeded to assess the carotid arteries of participants for evidence of atherosclerosis 
by carotid intima-media thickness (CIMT).  They concluded that those individuals with 
the highest systolic blood pressures at a young age also had the greatest amount of 
thickening of the carotid arteries, thus increasing the risk of adverse cardiovascular 
events (Vos, 2003).   
   Even neurologic effects have been linked with elevated BP.  Central nervous 
system dysfunction is a problem in individuals with long-standing hypertension.  Serious 
conditions such as cerebral hemorrhage and cerebral infarction can result from 
hypertension.  In a cerebral hemorrhage, elevated BP over an extended period of time 
can weaken arterial walls, and vascular aneurysms can result (Fisher, 2005).  In 
cerebral infarction, the pathophysiology is similar to that of an AMI, in which 
atherosclerotic lesions play a key role.  Less severe disorders such as headaches, 
especially occurring in the morning, decreased visual acuity, and light-headedness are 
other common early physical manifestations of chronic hypertension.  Ophthalmoscopic 
examination allows direct visualization of retinal vasculature, which can illustrate 
progressive changes secondary to essential hypertension (Fisher, 2005).  - 13 - 
A study by Lande et al. reviewed cognitive tests completed by 5,077 children.  Of 
the participants, 3.4% had elevated systolic BP, while 1.6% had elevated diastolic BP.  
Their findings concluded that children with either systolic or diastolic hypertension >90
th 
% had lower average scores on their tests (Lande, 2003).  Persistence in the detection 
and treatment of essential hypertension in the adolescent population will likely pay large 
dividends in the prevention of many disease states that are currently developing at a 
premature age.    
Monitoring Techniques  
  Hypertension in children and adolescents has been defined by the fourth report 
from the National High Blood Pressure Education Program (NHBPEP) as, “Systolic BP 
and/or diastolic BP greater than or equal to the 95th percentile for gender, age, and 
height on at least 3 separate occasions.” (NHBPEP, 2004)  The new BP tables contain 
the 50
th, 90
th, 95
th, and 99
th percentiles for analysis of BP in children and adolescents.  
BP between the 90
th and 95
th percentile in childhood has been designated “high 
normal”, or prehypertension (NHBPEP, 2004).  This differs from the Seventh Report of 
the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of 
High Blood Pressure (JNC VII) definition of prehypertension for all adults 18 years or 
older, which includes a systolic BP of 120-139 mmHg, and or a diastolic BP of 80-89 
mmHg (JNC VII, 2003).    
The Fourth Report insists that essential hypertension is a common occurrence in 
the adolescent population that is also readily detectable.  The report provides guidelines 
for clinicians that include monitoring children greater than 3 years old for elevated BP 
during every health care incident, acquiring BP measurements through auscultation with - 14 - 
an appropriately sized cuff, and confirming above normal readings with repeat 
measurements.  The systolic blood pressure is noted by the onset of Korotkoff sounds.  
Diastolic BP is marked by the cessation of Korotkoff sounds (the fifth Korotkoff sound).  
Oscillometric devices can be used for clinical BP monitoring, but elevated levels should 
be reevaluated by auscultation (NHBPEP, 2004).  
Blood pressure is consistently changing throughout the day in response to 
various stimuli.  Temporary fluctuations in BP can produce drastically elevated 
measurements, as seen in “white-coat hypertension.”  In this condition patients have BP 
greater than the 95
th percentile when measured in a clinical setting, although they are 
otherwise normotensive.  These individuals often require evaluation through ambulatory 
blood pressure monitoring (ABPM).  This consists of utilizing devices that periodically 
measure BP over an extended period of time (usually 24 hours), thus gaining a better 
understanding of the patient’s average daily arterial pressure (NHBPEP, 2004). 
An article by Sinaiko, done in 2001, points out that ABPM appears to be an 
attractive option in the assessment of children and adolescents with mild hypertension.  
However, at that particular time, not enough clinical evidence had been accomplished 
demonstrating the effectiveness of this technique (Sinaiko, 2001).  A more recent study 
by Lurbe et al. claims that research over the last several years has significantly 
improved previous shortages of normative data in ABPM.  Improvements have also 
been seen with analysis of data, thus giving health care providers a better indication of 
when and how to treat adolescents with hypertension (Lurbe, 2004).  This study points 
out another important concept.  As already mentioned, hypertension is classified in the 
adolescent population as BP greater than the 95
th percentile values based on height, - 15 - 
age, and gender.  As the prevalence of obesity continues to increase in this country, 
blood pressure among adolescents will climb, ultimately allowing for higher blood 
pressures to be considered normal (Lurbe, 2004).   
  Not all experts are convinced that essential hypertension is a significant problem 
in the adolescent population.  Unlike their recommendation for adults, the U.S. 
Preventive Services Task Force (USPSTF) has determined that there is inadequate 
evidence supporting the practice of screening adolescents for hypertension as a 
preventative measure in the development of cardiovascular disease.  The Task Force 
does recognize that many other professional organizations, including the American 
Academy of Pediatrics (AAP), American Heart Association (AHA), and American 
Medical Association (AMA), recommend routine screening, especially to assist in 
identifying secondary causes of hypertension, such as renal disease.  Therefore, the 
USPSTF essentially leaves blood pressure screening as a matter of clinical judgement 
(USPSTF, 2003).    
Staging and Treatment 
  The Fourth Report has developed staging of BP according to the extent that the 
blood pressure exceeds the 95
th percentile.  This staging was proposed as a guide to 
assist in the most appropriate treatment for each individual patient.  Stage 1 
hypertension ranges from the 95
th percentile to 5 mmHg greater than the 99
th percentile.  
Stage 2 includes BP levels that are greater than 5 mmHg above the 99
th percentile.  
Typically, stage 1 hypertension allows time for evaluation prior to initiating 
pharmacologic treatment.  Those with stage 2 hypertension often need more prompt 
evaluation and pharmacologic therapy, especially if they are symptomatic.  This staging - 16 - 
was designed with the intent to parallel the staging set forth by the JNC VII (NHBPEP, 
2004). 
  Conservative reduction techniques are nearly always attempted initially in the 
management of adolescents with essential hypertension.  The most commonly 
employed non-pharmacologic lifestyle changes include weight reduction in overweight 
individuals, dietary modification, regular physical activity, sodium restriction, elimination 
of caffeine, moderation of alcohol consumption, and smoking cessation.   
  As previously discussed, obesity has been shown to drastically impact the 
development of high blood pressure.  Studies by Brownell et al. and Rocchini et al. have 
shown that weight loss can successfully lower blood pressure in many cases (Brownell, 
1983 & Rocchini, 1988).  Not only does weight loss lower BP, it also reduces other 
cardiovascular risk factors, such as insulin resistance and dyslipidemia.  Unfortunately, 
weight loss is a very difficult achievement for many.  Adolescents in the U.S. today are 
less likely to participate in physical fitness activities, and are more prone to sedentary 
behavior, such as watching television, spending time on the computer, and playing 
video games.  The AAP currently recommends no more than 1-2 hours of television 
watching per day (AAP, 1995).  Strategies aimed at reducing sedentary behavior should 
be discussed between the concerned clinician and the patient.  Aerobic activity, such as 
walking, running, swimming, or cycling should be emphasized as the preferred method 
of exercise. 
Cookies, chips, and fast food seem to have replaced fruits and vegetables as 
major dietary components for many adolescents.  Based on the Food Guide Pyramid, 
increasing fresh fruit and vegetable intake, and whole grain consumption while - 17 - 
decreasing juice, refined carbohydrates, sweetened carbonated beverages, and 
saturated and trans fats will place individuals in a better position to optimize their overall 
health (Dietary Guidelines, 2000).  A large percentage of adolescents would likely 
benefit from nutritional intervention by a specialist, possibly including counseling for the 
patient and their family. 
The Fourth Report indicates when to initiate pharmacologic therapy in children 
and adolescents.  Naturally, patients with secondary causes of hypertension should 
receive drug therapy.  Also, those that are unresponsive to conservative treatment, 
patients with symptomatic essential hypertension, and those with established target-
organ damage, should be strongly considered for pharmacologic therapy (NHBPEP, 
2004).  If treatment is initiated for adolescents with essential hypertension, the target BP 
should be <95
th percentile for gender, age, and height.  In those patients with co-morbid 
diseases such as diabetes, or renal disease, the ideal BP should be <90
th percentile 
(NHBPEP, 2004).  Many experts agree that adolescents with essential hypertension 
should be started on a single medication at the lowest recommended starting dose.  If 
required, another agent with a complimentary mode of action can be added to the 
regimen. An example would be a diuretic prescribed with an angiotensin-receptor 
blocker.    
Which drug to begin with remains a matter of preference for the prescribing 
clinician.  Thus far, there have been no studies illustrating the long-term effects that 
antihypertensive medications may have on the overall health of patients beginning 
treatment at such a young age.  Currently accepted classes of medications for this 
population include diuretics, angiotensin-converting enzyme (ACE) inhibitors, - 18 - 
angiotensin-receptor blockers, B-blockers, and calcium channel blockers (NHBPEP, 
2004).  Physicians should keep in mind that Beta-adrenergic antagonists (B-blockers) 
and diuretics are not typically the ideal antihypertensives for those patients concurrently 
attempting to lose weight through a relatively rigorous workout regimen.  These two 
classes are actually banned by some sports organizations (Swain, 1997).   
As the obesity epidemic continues to flourish in the United States, essential 
hypertension in the adolescent population will undoubtedly receive increased attention.  
The past several years have already seen several studies examining the efficacy of 
various antihypertensive medications in adolescent patients.  A study by Ellis et al. 
examined use of the angiotensin-receptor blocker losartan, for treating children and 
adolescents with hypertension.  Participants had either essential hypertension or 
hypertension secondary to renal disease.  Losartan was found to provide adequate 
antihypertensive and renoprotective effects.  Nearly all participants were within the 
normotensive range, even at the study follow-up at 2.42 years (Ellis, 2003).  
Another study by Flynn et al. assessed Amlodipine, a dihydropyridine calcium 
channel blocker, in the treatment of children and adolescents with either primary or 
secondary hypertension.  At the time of publication, this was the largest placebo-
controlled clinical trial involving hypertensive children and adolescents.  The study found 
that once daily Amlodipine significantly lowered systolic BP, and to a lesser extent 
diastolic BP, in hypertensive participants.  Approximately 31% of those involved had 
primary hypertension.  Ultimately, the underlying cause of hypertension had no 
influence on the response to the medication.  Review of this study showed that only 
34.6% of the participants achieved a reduction in systolic BP <95
th%.  The study offered - 19 - 
that subtherapeutic doses of Amlodipine were administered to the participants, and 
implied higher doses would produce more impressive results (Flynn, 2004).      
One final study tested the ACE inhibitor lisinopril, as an antihypertensive in 
children ages 6-16 years.  The study examined 115 randomized participants, grouped 
into one of three different dosage groups (high, middle, low).  Their results showed an 
effective reduction in BP within 2 weeks in most patients (Soffer, 2002).  As essential 
hypertension becomes an even greater problem in the adolescent population, other 
studies examining the efficacy of various antihypertensive medications will need to be 
accomplished in the near future. 
  The purpose of this study was to gain an understanding of current knowledge 
levels between pediatrician providers and non-pediatrician providers in detecting and 
appropriately treating adolescents (ages 12-17) with essential hypertension.  The 
relevance of this study is associated with the increasing prevalence of obesity, and 
often subsequent increase in arterial blood pressure, among adolescents in the U.S.  
Based on research illustrating the harmful effects of long-standing essential 
hypertension, it would be simply unacceptable to fail in identifying and adequately 
treating patients in this population.  As essential hypertension becomes a more common 
problem in adolescents, healthcare providers must be highly proficient in recognizing 
abnormal BP measurements, and knowledgeable with BP reduction methods.          
Problem Statement: 
  Elevated arterial blood pressure among adolescents in the U.S. has become an 
area of significant concern due to increasing prevalence.  Long-standing poorly-- 20 - 
controlled essential hypertension has been directly linked to very serious conditions 
including, heart disease, stroke, and kidney disease.    
Research Hypothesis: 
  Pediatrician providers are more proficient than non-pediatrician providers in 
detecting and appropriately treating adolescents (ages 12-17) with essential 
hypertension. 
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METHODS 
Review of Literature 
  Following the initial research proposal, pertinent literature was gathered utilizing 
internet search engines: Medline, Pub Med, CINAHL, and Google.  All available articles 
were collected using various combinations of the keywords, adolescents, essential 
hypertension, obesity, metabolic syndrome, effects of long-standing hypertension, and 
treatment of adolescents with hypertension.    
Survey Distribution 
In our study, we designed an anonymous knowledge-based survey that was 
distributed to primary care oriented providers in the fields of family medicine, pediatrics, 
and emergency medicine.  The survey was intended to aid in assessing knowledge 
levels of sampled healthcare providers regarding essential hypertension in the 
adolescent population (ages 12-17).  We designed our survey questions based on the 
most recent guidelines set forth by JNC VII (2003) and The Fourth Report on the 
Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and 
Adolescents (2004).  Participants were asked to evaluate several hypothetical 
adolescent patients with essential hypertension.  We attempted to assess their ability to 
accurately diagnose individuals with elevated BP.  We also included questions 
pertaining to hypertension treatment options, and questions that helped elicit provider 
familiarity with current guidelines.  A copy of the survey, along with appropriate 
responses for the knowledge-based portion, is shown in the appendix.   
 Following  Institutional  Review Board (IRB) approval, we hand-delivered our 
surveys to multiple ProMedica and Medical University of Ohio (MUO) locations, - 22 - 
beginning in June of 2005.  Arrangements were made with office managers, enabling us 
to leave our surveys.  Once finished, healthcare providers were asked to place 
completed surveys, without any identifying information included, into secure drop-boxes 
located at their individual clinical sites.  Preliminary collections were conducted in early 
July.  At the same time, courteous reminders were given to office managers at locations 
with poor turnouts to encourage providers to complete their surveys if they had not 
already done so.  Final collections were carried out in early August 2005.   
Participants 
  With the assistance of several healthcare providers and office managers at 
participating institutions, it was determined that a total of approximately 150 potential 
participants affiliated with ProMedica and MUO could be sampled for this study.  As 
previously mentioned, participants had a background in family practice, pediatrics, or 
emergency medicine.  Providers from these specialties were selected based on their 
potential for regularly encountering adolescents with essential hypertension in a primary 
care setting. Allopathic and Osteopathic physicians, physician assistants, and nurse 
practitioners comprised the spectrum of healthcare providers.  No other exclusion 
criteria were used.     
Statistical Analysis 
  All data analyses were performed using SPSS software.  A one-way analysis of 
variance (ANOVA) was used for assessment of data.  For post-hoc testing, Tukey’s 
HSD was used to analyze differences in the knowledge mean scores based on type of 
practice.  Statistical significance was defined as P<0.05.  
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RESULTS 
Characteristics of Respondents  
 
  Table 1 summarizes the demographic data of the 43 respondents involved in this 
study.  The total number of surveys distributed to potential participants was 150.  Of 
those, 43 were returned at least partially completed.  This resulted in a 28.6% return 
rate overall.  Forty-nine percent of our respondents were male, while 51% were female.  
Thirty-three percent were under the age of 35, 47% were between 36 and 45, and the 
other 20% were greater than 45 years of age.  Twenty-six percent had less than 2 years 
of experience in clinical practice, 37% had between 2 and 10 years of experience, and 
37% had greater than 10 years of clinical experience.  The majority of our participants 
held an M.D. (56%), while 7% were osteopathic physicians, 14% were physician 
assistants, 5% were nurse practitioners, and 19% were resident physicians (M.D. or 
D.O. not specified).  Finally, there was a relatively even distribution among participants 
in all medical specialties sampled (see figure 1).     
Healthcare Provider Knowledge Assessment  
 
  Of the 43 participants that submitted surveys, analysis of overall knowledge 
regarding essential hypertension in the adolescent population (ages 12-17) was 
assessed.  The maximum possible score on the knowledge-based portion of the survey 
was a 13.  Available demographic variables of the respondents were compared with 
overall scores on the quiz.  Among age, gender, years in clinical practice, and the 
professional degree held, there were no significant differences (P>0.05) among 
healthcare providers. Interestingly, there was also no correlation between overall scores - 24 - 
on the quiz and the approximate percentage of patients seen by providers that fall within 
the range of 12-17 years.  
  There was, however, a significant finding between overall knowledge of 
adolescent hypertension and medical specialty [Reliability Coefficient of alpha=0.7800 
(which indicates the stability of our measurements); P<0.001].  Individuals in emergency 
medicine performed at a much lower level on the hypertension quiz than those in family 
practice and pediatrics.  Family practice providers scored just slightly lower than 
pediatric providers on the quiz.  A comparison of mean scores on the survey between 
the three medical specialties can be seen in Figure 2.  
  Emergency medicine providers were largely unfamiliar with JNC VII standards 
regarding hypertension in the adolescent population (see Figure 3).  They were also 
less likely to believe essential hypertension is a significant problem in adolescents (see 
figure 4).  When resorting to pharmacologic intervention, participants showed significant 
diversity in the initial choice of medication (see Figure 5).  This finding is not surprising 
based on the lack of scientific research indicating the overall best drug for use in this 
population (NHBPEP, 2004).  Family practitioners did, however, show a strong 
preference for the usage of diuretics as a first-line agent. 
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DISCUSSION AND CONCLUSIONS 
  As mentioned earlier, essential hypertension in the adolescent population 
(ages 12-17) continues to increase in prevalence in the U.S.  Our study looked at the 
knowledge levels of healthcare providers in a variety of settings pertaining to this topic.  
Results indicated, as we hypothesized, that pediatric providers, followed closely by 
family practitioners, are significantly more proficient than emergency medicine providers 
at detecting and treating adolescents (ages 12-17) with essential hypertension.  The 
vast majority of emergency medicine providers sampled in our study were completely 
unfamiliar with JNC VII standards regarding detection and treatment of adolescents with 
essential hypertension.  This is troubling since there are certainly different guidelines to 
follow when detecting and treating hypertension in adults as opposed to adolescents.   
  Essential hypertension in adolescents has become much more common than in 
previous decades partially due to sedentary lifestyle habits, and poor dietary choices 
(Cook, 2004).  When the onset of essential hypertension is early in life, the detrimental 
effects this process has on the body inevitably begin at a premature age.  It seems only 
logical that the major complications resulting from long-standing essential hypertension 
(heart disease, kidney damage, etc.) would occur at a much younger age as well.  
However, no long-term studies illustrating this theory have been conducted so far (Bao, 
1995). 
  Emergency medicine providers are faced with a vast array of medical conditions 
on a daily basis.  Understandably, these individuals cannot reasonably be expected to 
maintain a level of expertise comparable to that of family practitioners and pediatrician 
providers regarding essential hypertension in adolescents.  However, abnormal vital - 26 - 
signs in any patient should be immediately recognizable to emergency medicine 
providers for obvious reasons.  In any adolescent patient presenting with an elevated 
BP, this discrepancy must first be acknowledged as abnormal.  Once an abnormal 
reading is documented, then subsequent measures can be taken.  Secondary causes of 
hypertension should be ruled out.  If no secondary cause is found, it is highly unlikely 
that pharmacologic treatment for presumed essential hypertension would be initiated in 
the emergency department, unless the reading was severely elevated, or there was 
evidence of end-organ damage (NHBPEP, 2004).  Non-pharmacologic therapy could 
then be discussed briefly in the emergency department.  Referrals to pediatric 
specialists could also be arranged if necessary.   
  Access to healthcare remains a burden for many in the U.S.  As the number of 
uninsured continues to climb, people will turn more and more to emergency 
departments for their primary care needs.  Providers in these settings must be skilled in 
recognizing elevated arterial pressures in any age group.   
  According to our results, conservative (non-pharmacologic) BP reduction 
methods are commonly recommended to patients by providers in all specialties.  This is 
reassuring because the vast majority of adolescents (ages 12-17) with essential 
hypertension can be well-controlled with conservative measures alone (ATP III, 2001).    
  As mentioned earlier, experts have not yet determined a best first-line agent that 
should be used in the treatment of adolescents (ages 12-17) with essential 
hypertension.  Currently, ACE inhibitors, Beta-Blockers, calcium-channel blockers, 
angiotensin-receptor blockers, and diuretics, are all approved as initial agents 
(NHBPEP, 2004).  Our study participants showed a great deal of diversity in their - 27 - 
selection of first-line medications for adolescents.  Family practice providers seemed to 
moderately favor administering a diuretic initially over any other prescription medication.  
There were no other obvious prescribing trends among specialties.  As further studies 
indicating the efficacy and safety of various anti-hypertensive medications in this 
population are conducted, more specific guidelines pertaining to treatment will certainly 
be established.   
  Our study has several important limitations.  First, our sample size was limited, 
obtaining an overall return rate of only 28.6%.  Also, participants were selected only 
from Toledo area clinical settings.  It is likely that results would vary significantly based 
on the geographic setting.  For example, in parts of Arizona and Texas, where many 
illegal immigrants commonly use emergency departments as their only means of 
healthcare, clinicians may be more likely to prescribe anti-hypertensive medications 
than emergency providers in other locations (Associated Press, 2004).  Secondly, the 
surveys were filled out in a non-controlled setting.  As participants discovered that the 
survey tested knowledge of essential hypertension in adolescents, they may have 
referenced a pediatric blood pressure assessment chart.  According to one individual 
that assisted in data collection for this study, many potential participants were reluctant 
to fill surveys out initially because they were unsure of the correct answers. A large 
percentage of people proceeded to take surveys home overnight for completion before 
turning them in.  It is difficult to determine if this practice played a role in falsely 
elevating average scores in any of the groups sampled.    
   Future research could be well-served by sampling healthcare providers from a 
variety of geographic locations, rather than utilizing participants from only one city.  - 28 - 
Also, as further studies illustrating the efficacy and long-term safety of anti-hypertensive 
medications used in adolescent populations are conducted, researchers could survey 
healthcare providers to ensure they are complying with the most recent treatment 
guidelines.     
     In conclusion, it is evident from our data that not all primary care providers are 
making their best effort to combat the current rise in adolescents (ages 12-17) with 
essential hypertension.  While pediatrician providers and family practitioners performed 
relatively well on our knowledge-assessment survey, emergency medicine providers 
showed that there is certainly room for improvement.  Again, emergency medicine 
providers function in an often chaotic setting.  It is not expected that they become the 
foremost experts in all aspects of essential hypertension in adolescents.  It is well 
known that treatment for essential hypertension would not likely be initiated in the 
emergency department for a number of reasons.  However, emergency medicine 
providers must become familiar with current guidelines regarding hypertension in 
pediatrics and adolescents.  
   It is well-documented in scientific literature that long-standing essential 
hypertension is a major contributor to premature morbidity and mortality.  As the 
incidence of obesity continues to grow in adolescents, essential hypertension will occur 
in even greater frequency within this population.  Many of these individuals also have 
coexisting problems with dyslipidemia, and type 2 diabetes mellitus, to make matters 
worse.  To prevent the major complications associated with essential hypertension from 
eventually occurring, healthcare providers must make a greater effort to correctly 
identify adolescents with abnormal BP measurements.  Once detected and discussed - 29 - 
with patients and their families, appropriate reduction methods can be arranged as 
necessary.  However, without recognition of an elevated BP, it is unlikely patients will be 
aware there is even a problem in need of fixing in the first place.  As healthcare 
providers, especially those of us in primary care settings, we must pay particularly close 
attention to this growing problem.  Physician assistants are in a unique position to 
contribute significantly in the battle against essential hypertension in the adolescent 
population. Maintaining proficiency in current detection and treatment guidelines is 
crucial to achieving success in preventing the harmful effects of long-standing 
hypertension in adolescents.  
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Tables 
 
 
Gender 
N= 
(%) 
 
Male 
21 
49% 
Female 
22 
51% 
 
Age of 
respondents 
(in years) 
N= 
(%) 
 
Less than 35 
 
 
14 
33% 
 
36-45 
 
 
20 
47% 
46-55 
 
 
8 
19% 
56 or 
greater 
 
 
1 
2% 
Total number 
of years in 
practice 
N= 
(%) 
 
 
Less than 2 
 
11 
26% 
2-10 
 
 
16 
37% 
11-20 
 
 
10 
23% 
21 or 
greater 
 
 
6 
14% 
Level of 
training 
 
N= 
(%) 
 
MD 
 
 
24 
56% 
DO 
 
 
3 
7% 
PA 
 
 
6 
14% 
NP 
 
 
2 
5% 
Resident 
Physician 
 
8 
19% 
Medical 
Specialty 
 
N= 
(%) 
 
Family 
Practice 
 
16 
37% 
Pediatrics 
 
 
17 
40% 
Emergency 
Medicine 
 
10 
23% 
 
Table 1. Demographic characteristics of participants involved in study. 
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Figure 1.  Breakdown of study participants by medical specialty. 
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Figure 2.  Mean Score on Hypertension Knowledge Assessment Survey by Medical 
Specialty.  Maximum score was a 13.  
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  Figure 3.  Familiarity with JNC VII standards by medical specialty. 
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  Figure 4.  Belief among medical specialties regarding the significance of 
  essential hypertension in adolescents (ages 12-17).  
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Figure 5.  Pharmacologic treatment of choice among study participants for adolescents 
(ages 12-17) with essential hypertension.  ACE; angiotensin-converting enzyme 
inhibitor, ARB; angiotensin-receptor blocker, CCB; calcium-channel blocker.  
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Appendix 
1.  What is your gender? 
  Male   Female 
 
2.  What is your age? 
  <35     56-65 
  36-45             >65 
  46-55 
 
3.  How long have you been in clinical practice? 
  <2 yrs    16-20 yrs 
  2-5 yrs    21-25 yrs 
  6-10 yrs    >25 yrs 
  11-15 yrs     
 
4.  Select the appropriate level of medical training. 
  M.D.   P.A.   Resident Physician 
  D.O.   N.P.    
 
5.  Select your medical specialty. 
  Family Practice  Emergency Medicine     
  Pediatrics   Other 
 
6.  Please select the approximate percentage of patients aged 12-17 years you see throughout an  
     average week. 
  < 10%    51-75% 
  11-25%   76-100% 
  26-50% 
 
7.  How often are adolescent patients (ages 12-17) you see screened for high blood pressure? 
   X Every visit    Every well-visit only    Every sick-visit only    B.P is not routinely checked 
 
8.  Who performs blood pressure measurements on patients you see in your practice?   
I always check B.P. myself 
I often check B.P myself (an assistant sometimes does) 
I rarely check B.P myself (an assistant almost always does) 
I never check B.P. myself (an assistant always does) 
 
9.  Are you familiar with the Seventh US Joint National Committee on Prevention, Detection,  
     Evaluation, and Treatment of High Blood Pressure (JNC 7) standards regarding the management     
     of children and adolescents with high blood pressure? 
 X Yes 
      No 
 
10. If you are familiar with the national guidelines (JNC 7) where did you learn about them? 
  Professional journal  CME lecture    From a colleague       Unfamiliar  
  Internet website  Medical text  Other 
 
11. Is essential hypertension in the adolescent population (ages 12-17 years) a significant problem today in   
     America? 
 X Yes   No   Don’t Know 
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12. What is the minimal systolic blood pressure considered hypertensive in a 13 year-old adolescent male of average    
      height? 
  112 mmHg    X 126 mmHg 
  120 mmHg        131 mmHg 
 
 
13. What is the minimal diastolic blood pressure considered hypertensive in a 13 year-old adolescent male of  
       average height?   
70  mmHg    X 81 mmHg 
  76 mmHg           90 mmHg 
 
14. What is the minimal systolic blood pressure considered hypertensive in a 16 year-old adolescent female of  
      average height?   
      120 mmHg      134 mmHg 
 X 128 mmHg      140 mmHg 
 
15. What is the minimal diastolic blood pressure considered hypertensive in a 16 year-old adolescent female of  
      average height?   
      80 mmHg      87 mmHg 
 X 84 mmHg      90 mmHg 
 
16. According to JNC VII standards, should gender be considered when measuring blood pressure in adolescents? 
 X Yes   No   Don’t Know 
 
17. What non-pharmacologic (conservative) methods do you normally suggest to your  
        adolescent patients (ages 12-17 years) with essential hypertension? (Please choose all that apply) 
  Weight loss (if needed)   Smoking cessation         
  Dietary modifications    Meditation 
  Salt restriction     Yoga 
  Aerobic exercise      Other   At least 1 box marked counted as a correct answer 
 
18. Guidelines set forth by the JNC VII for when to initiate pharmacologic therapy in adults with essential         
      hypertension are the same as the guidelines for initiating treatment in adolescents. 
  Yes   X No    Don’t Know 
 
19. When would you initiate pharmacologic treatment for a 16 year-old adolescent male with documented essential  
      hypertension on three separate visits, who is also unresponsive to conservative therapy? Please choose a systolic  
      blood pressure. 
      130   150   >160 
 X 140   160 
 
20. When would you initiate pharmacologic treatment for a 16 year-old adolescent male with documented essential  
      hypertension on three separate visits, who is also unresponsive to conservative therapy? Please choose a   
      diastolic blood pressure. 
      80   90   >95 
 X 85   95 
 
21. What would be your first line of pharmacologic treatment for an adolescent with essential hypertension? 
 X Diuretic                 Alpha Adrenergic Antagonist 
 X ACE Inhibitor                       X Beta Adrenergic Antagonist 
 X Angiotensin Receptor Blocker        X Calcium Channel Blocker 
                Diuretic/ Potassium-sparing diuretic     Beta-Blocker/ Diuretic     
   ACE Inhibitor/ Diuretic             Angiotensin Receptor Blocker/ Diuretic 
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Abstract 
    Objective.  The goal of this study was to assess the proficiency of primary care 
providers in detecting adolescents (ages 12-17) with essential hypertension.  We also 
looked at treatment preferences, and familiarity with national guidelines regarding 
hypertension in the adolescent population.  Methods.  A knowledge-based survey was 
administered to approximately 150 healthcare providers in the fields of family practice, 
emergency medicine, and pediatrics throughout the Toledo area.  Results.   There was 
a significant finding between overall knowledge of adolescent hypertension and medical 
specialty (P<0.001).  Individuals in emergency medicine performed at a much lower 
level on the hypertension quiz than those in family practice and pediatrics.  Family 
practice providers, however, performed at a level just slightly below pediatrician 
providers.  Conclusion.   To prevent the major complications associated with essential 
hypertension, healthcare providers must make a greater effort to correctly identify 
adolescents with abnormal BP measurements.  Once detected, appropriate reduction 
methods can be arranged as necessary.   
 
 
 
 